Skip to main content
. 2021 Feb 12;41(2):BSR20203955. doi: 10.1042/BSR20203955

Table 3. KEGG pathway analysis based on EC–POI network (top 20 with P-value).

ID Pathway Genes n P-value
hsa04668 TNF signaling pathway PIK3CG, AKT1, CSF2, CASP3, IL6, TNF, CCL2, CEBPB, PTGS2, JUN, CREB1 11 1.06 × 10−8
hsa04915 Estrogen signaling pathway PIK3CG, AKT1, HSP90AA1, HSPA2, JUN, CREB1, ESR1, ESR2, SRC 9 1.11 × 10−6
hsa04919 Thyroid hormone signaling pathway ACTB, PRKCA, PIK3CG, AKT1, NCOA1, RXRA, ESR1, SRC, PRKCB 9 3.48 × 10−6
hsa04370 VEGF signaling pathway PRKCA, PIK3CG, AKT1, PTGS2, VEGFA, SRC, PRKCB 7 8.70 × 10−6
hsa04066 HIF-1 signaling pathway PRKCA, PIK3CG, AKT1, IL6, HMOX1, VEGFA, PRKCB 7 1.17 × 10−4
hsa04664 Fcϵ RI signaling pathway PRKCA, PIK3CG, AKT1, CSF2, TNF, PRKCB 6 2.10 × 10−4
hsa04015 Rap1 signaling pathway ACTB, PRKCA, PIK3CG, AKT1, CNR1, VEGFA, GRIN1, SRC, PRKCB 9 2.66 × 10−4
hsa04151 PI3K-Akt signaling pathway PRKCA, PIK3CG, AKT1, IL6, HSP90AA1, RXRA, CREB1, VEGFA, JAK1, CDK6, IL2 11 3.98 × 10−4
hsa04012 ErbB signaling pathway PRKCA, PIK3CG, AKT1, JUN, SRC, PRKCB 6 6.63 × 10−4
hsa05166 HTLV-I infection PIK3CG, AKT1, CSF2, IL6, TNF, JUN, CREB1, JAK1, IL2 9 9.45 × 10−4
hsa04150 mTOR signaling pathway PRKCA, PIK3CG, AKT1, TNF, PRKCB 5 1.21 × 10−3
hsa04660 T cell receptor signaling pathway PIK3CG, AKT1, CSF2, TNF, JUN, IL2 6 1.24 × 10−3
hsa04510 Focal adhesion ACTB, PRKCA, PIK3CG, AKT1, JUN, VEGFA, SRC, PRKCB 8 1.30 × 10−3
hsa05321 Inflammatory bowel disease (IBD) IL6, TNF, JUN, IL1A, IL2 5 1.74 × 10−3
hsa05214 Glioma PRKCA, PIK3CG, AKT1, CDK6, PRKCB 5 1.85 × 10−3
hsa05145 Toxoplasmosis AKT1, CASP3, TNF, HSPA2, JAK1, ALOX5 6 1.91 × 10−3
hsa04917 Prolactin signaling pathway PIK3CG, AKT1, ESR1, ESR2, SRC 5 2.55 × 10−3
hsa04071 Sphingolipid signaling pathway PRKCA, PIK3CG, AKT1, TNF, ABCC1, PRKCB 6 2.79 × 10−3
hsa04650 Natural killer cell-mediated cytotoxicity PRKCA, PIK3CG, CSF2, CASP3, TNF, PRKCB 6 3.00 × 10−3
hsa04010 MAPK signaling pathway PRKCA, AKT1, CASP3, TNF, HSPA2, JUN, IL1A, PRKCB 8 4.16 × 10−3